Persistent CD19+ B cell lymphopenia in critically ill COVID-19 patients 50 days after symptom onset
IntroductionLong COVID (LC) poses a persistent challenge in clinical practice due to limited understanding of its etiology. LC is hypothesized to stem from aberrant immune responses in COVID-19. Vaccinations, which boost immune cells to restore function, could help ease LC symptoms.MethodsTo exclude...
Saved in:
| Main Authors: | Hui An, Ting Li, Xinyue Zhang, Hao Hu, Chen Zhang, Yongyu Wang, Shengwei Jin, Ming Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1488607/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset
by: Hui An, et al.
Published: (2024-11-01) -
Diverse immune cell profiles in ASFV-associated lymphopenia
by: Wenjing Xiong, et al.
Published: (2024-12-01) -
Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy
by: Yeon-Woo Kang, et al.
Published: (2024-12-01) -
Case report of secondary T-cell deficiency following the AstraZeneca COVID-19 vaccine
by: Amin Esmailian, BSC (Hons), MD, et al.
Published: (2024-11-01) -
The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma
by: Danjing Luo, et al.
Published: (2024-12-01)